Simnova Secures FDA IND for CAR‑NK Therapy in SLE
CompanyDrug

Simnova Secures FDA IND for CAR‑NK Therapy in SLE

Sinopharm Secures NMPA Approval for QuadrivalentHPV Vaccine
CompanyDrug

Sinopharm Secures NMPA Approval for QuadrivalentHPV Vaccine

Hua Medicine Secures Hong Kong NDA Acceptance for Dorzagliatin, First‑In‑Class Glucokinase Activator
CompanyDrug

Hua Medicine Secures Hong Kong NDA Acceptance for Dorzagliatin, First‑In‑Class Glucokinase Activator

Xinhua Pharma Wins China Trial Approval for Dual‑Mechanism PAH Drug LXH‑1211
CompanyDrug

Xinhua Pharma Wins China Trial Approval for Dual‑Mechanism PAH Drug LXH‑1211

Simcere Secures FDA Approval for ADC SIM0609 in Advanced Solid Tumors
CompanyDrug

Simcere Secures FDA Approval for ADC SIM0609 in Advanced Solid Tumors

CMS Wins NMPA Green Light for Phase‑3 Trial of MG‑K10 Anti‑IL‑4Rα in Chronic Urticaria
CompanyDrug

CMS Wins NMPA Green Light for Phase‑3 Trial of MG‑K10 Anti‑IL‑4Rα in Chronic Urticaria

Eisai & Biogen Secure Leqembi China Maintenance Approval
CompanyDrug

Eisai & Biogen Secure Leqembi China Maintenance Approval

HanX Biopharmaceuticals Secures NMPA Approval for HX044‑HX008 PD‑1 Therapy Combination in Advanced Solid Tumors
CompanyDrug

HanX Biopharmaceuticals Secures NMPA Approval for HX044‑HX008 PD‑1 Therapy Combination in Advanced Solid Tumors

Novatim Partners with VRise to Launch KQ‑2003 CAR‑T in India
CompanyDeals

Novatim Partners with VRise to Launch KQ‑2003 CAR‑T in India

CMS Announces Phase 3 Success of Ruxolitinib Cream in Atopic Dermatitis
CompanyDrug

CMS Announces Phase 3 Success of Ruxolitinib Cream in Atopic Dermatitis

Merck Names Kai Beckmann as Incoming CEO, Signals Smooth Leadership Transition
Company

Merck Names Kai Beckmann as Incoming CEO, Signals Smooth Leadership Transition

Trump’s New Pharmaceutical Tariffs Will Be Limited to 15% for EU and Japan, White House Says
Policy / Regulatory

Trump’s New Pharmaceutical Tariffs Will Be Limited to 15% for EU and Japan, White House Says